MRKR — Marker Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1094038 ·
Last close
$1.15
Market Cap
$19.17M
52W High
$2.46
52W Low
$0.84
ADV30
75,333
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,938,787 | -1,826,229 | 14,585,485 | 11,331,023 | 2,420,021 |
| Mar 2026 | 0 | — | -3,320,844 | -3,179,278 | 17,434,008 | 14,915,519 | 3,638,050 |
| Dec 2025 | 0 | — | -1,883,994 | -1,703,210 | 19,070,997 | 16,068,048 | 2,274,183 |
| Sep 2025 | 0 | — | -2,136,726 | -1,998,662 | 21,734,830 | 17,589,978 | 3,345,937 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,918,536
Investing CF
$0
Financing CF
$9,863,983
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.97
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-462,360,076
Inventory
—
Receivables
$1,377,300
ST Investments
—
EBIT TTM
$-11,602,597
Pretax Income TTM
$-10,911,870
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,546,669
EBITDA
—
Free Cash Flow
$-6,227,035
Enterprise Value
$7,843,073
Total Cash
$11,331,023
Total Debt
$0
Shares Out
16,673,127
Trailing EPS
$-0.38
Book Value
$0.73
ROE
-76.9%
ROA
-40.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -12,437,291 | -12,163,620 | 19,070,997 | 2,274,183 | 16,796,814 | -12,014,081 |
| Dec 2024 | 0 | -11,118,372 | -10,731,315 | 22,022,860 | 3,464,454 | 18,558,406 | -10,910,324 |
| Dec 2023 | 3,311,133 | -11,270,245 | -8,236,814 | 17,127,391 | 3,074,848 | 14,052,543 | -16,439,961 |
| Dec 2022 | 0 | -19,791,004 | -29,930,694 | 34,422,184 | 14,821,147 | 19,601,037 | -26,972,153 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.53
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | $18.99M | $9.76 | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | $18.96M | $1.90 | — |
| NEUP | Neuphoria Therapeutics Inc. | $19.73M | $3.65 | — |
| MCUJF | MEDICURE INC | $19.83M | $1.90 | — |
| PTN | PALATIN TECHNOLOGIES INC | $17.97M | $10.10 | — |
News headlines (Yahoo Finance, 1h cache)
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
2026-09-22 12:00 · Yahoo
High Growth Tech Stocks To Watch In US June 2026
2026-06-03 11:38 · Yahoo
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
2026-08-06 13:50 · Yahoo
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
2026-06-26 08:59 · Yahoo
Exploring 3 High Growth Tech Stocks In The US Market
2026-06-05 17:38 · Yahoo
US High Growth Tech Stocks with Promising Potential
2026-06-05 11:38 · Yahoo
3 High Growth Tech Stocks To Watch In The US Market
2026-06-02 11:38 · Yahoo
Top 3 High Growth Tech Stocks in the US Market
2026-06-01 17:38 · Yahoo
High Growth Tech Stocks in US for May 2026
2026-05-29 17:38 · Yahoo
High Growth Tech Stocks in the US for May 2026
2026-05-26 17:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.